SREBF1 and metabolic dysfunction-associated steatotic liver disease: The extent of NAFLD and related indicators of disease progression were evaluated, and the possible involvement of the PPAR-α signaling pathway and SREBP-1c in the regulation of NAFLD progression was examined.